1207 TRIPLE THERAPY WITH DACLATASVIR (DCV; BMS-790052), PEGINTERFERON ALFA-2A AND RIBAVIRIN IN HCV-INFECTED PRIOR NULL AND PARTIAL RESPONDERS: 12-WEEK RESULTS OF PHASE 2B COMMAND-2 TRIAL

✍ Scribed by Ratziu, V.; Gadano, A.; Pol, S.; Hézode, C.; Ramji, A.; Cheng, W.; Sulkowsk, M.; Everson, G.; Diva, U.; McPhee, F.; Wind-Rotolo, M.; Hughes, E.A.; Yin, P.D.; Schnittman, S.

• Book ID: 122001814
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 71 KB
• Volume: 56
• Category: Article
• ISSN: 0168-8278
• DOI: 10.1016/S0168-8278(12)61219-7